TICAM-1/TRIF associates with Act1 and suppresses IL-17 receptor-mediated inflammatory responses

Added 111 days ago (27.01.2022)
Authors: Miyashita, Y., Kouwaki, T., Tsukamoto, H., Okamoto, M., Nakamura, K., Oshiumi, H.
Read article